Table 1.
Theories | Evidence |
---|---|
Alter caspase activity | HIV PIs block Fas and TNF mediated apoptosis HIV PIs not block caspase -1, -3, -4, -5, -6, -7, -8, or -9 activity in cell models |
Inhibit Calpain activity | HIV PIs inhibit apoptosis in cell systems where calpains are activated HIV PIs blocked m-calpain activation in U937 cells HIV PIs inhibited activity of both m- and -μ calpain isoforms in PC12 cells HIV PI did not inhibit m- or μ-calpain hydrolysis or activation at lower, physiologic, concentrations |
Alter levels of apoptosis regulatory proteins | No change in Fas protein levels after HIV PI treatment No change in RNA levels of Fas, Fas L, and TNF after HIV PI treatment No change in Bcl-2, Bax, and Bcl-XL after HIV PI treatment |
Maintain Mitochondrial Transmembrane Potential | HIV PIs maintain mitochondrial membrane integrity after apoptosis stimuli HIV PIs prevent cytochrome c release from mitochondria after apoptosis stimuli ANT (adenine nucleotide translocator) necessary for HIV PI to block mitochondria mediated apoptosis |